Search research articles
Contact Us
Filters
Showing results (41-50 of 87) with videos related to
Page
of 9
Sort By:
The Journal of Infectious Diseases
|
March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir
David Wyles, Michael Saag, Rolando M Viani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
Michael Saag, Rukmini Balu, Elizabeth Phillips, et al.
AIDS Research and Human Retroviruses
|
April 27, 2010
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174
Kimberly Smith, Lu Zheng, Ronald Bosch, et al.
Lancet (London, England)
|
April 5, 2014
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Bonaventura Clotet, Judith Feinberg, Jan van Lunzen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2009
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment
Colleen F Kelley, Christina M R Kitchen, Peter W Hunt, et al.
Pain Medicine (Malden, Mass.)
|
July 19, 2016
Using Patient Perspectives to Inform the Development of a Behavioral Intervention for Chronic Pain in Patients with HIV: A Qualitative Study
Jessica S Merlin, Sarah R Young, Mallory O Johnson, et al.
Contemporary Clinical Trials Communications
|
April 27, 2018
Intervention Mapping to develop a Social Cognitive Theory-based intervention for chronic pain tailored to individuals with HIV
Jessica S Merlin, Sarah R Young, Mallory O Johnson, et al.
Plos Medicine
|
April 25, 2012
Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification
Livio Azzoni, Andrea S Foulkes, Yan Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 16, 2021
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study
Debbie Hagins, Princy Kumar, Michael Saag, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 19, 2016
Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis
H Nina Kim, Robin Nance, Stephen Van Rompaey, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 87) with videos related to
Sort By:
Page
of 9
The Journal of Infectious Diseases
|
March 23, 2017
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir
David Wyles, Michael Saag, Rolando M Viani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2008
High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
Michael Saag, Rukmini Balu, Elizabeth Phillips, et al.
AIDS Research and Human Retroviruses
|
April 27, 2010
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174
Kimberly Smith, Lu Zheng, Ronald Bosch, et al.
Lancet (London, England)
|
April 5, 2014
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Bonaventura Clotet, Judith Feinberg, Jan van Lunzen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 6, 2009
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment
Colleen F Kelley, Christina M R Kitchen, Peter W Hunt, et al.
Pain Medicine (Malden, Mass.)
|
July 19, 2016
Using Patient Perspectives to Inform the Development of a Behavioral Intervention for Chronic Pain in Patients with HIV: A Qualitative Study
Jessica S Merlin, Sarah R Young, Mallory O Johnson, et al.
Contemporary Clinical Trials Communications
|
April 27, 2018
Intervention Mapping to develop a Social Cognitive Theory-based intervention for chronic pain tailored to individuals with HIV
Jessica S Merlin, Sarah R Young, Mallory O Johnson, et al.
Plos Medicine
|
April 25, 2012
Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification
Livio Azzoni, Andrea S Foulkes, Yan Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 16, 2021
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study
Debbie Hagins, Princy Kumar, Michael Saag, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 19, 2016
Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis
H Nina Kim, Robin Nance, Stephen Van Rompaey, et al.
Page
of 9